Therapeutic Potential of Marine Peptides in Prostate Cancer: Mechanistic Insights

Mar Drugs. 2022 Jul 22;20(8):466. doi: 10.3390/md20080466.

Abstract

Prostate cancer (PCa) is the leading cause of cancer death in men, and its treatment is commonly associated with severe adverse effects. Thus, new treatment modalities are required. In this context, natural compounds have been widely explored for their anti-PCa properties. Aquatic organisms contain numerous potential medications. Anticancer peptides are less toxic to normal cells and provide an efficacious treatment approach via multiple mechanisms, including altered cell viability, apoptosis, cell migration/invasion, suppression of angiogenesis and microtubule balance disturbances. This review sheds light on marine peptides as efficacious and safe therapeutic agents for PCa.

Keywords: antiangiogenic; antimetastatic; antimitotic; apoptosis; cell cycle arrest; marine peptides.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents* / chemistry
  • Antineoplastic Agents* / pharmacology
  • Antineoplastic Agents* / therapeutic use
  • Apoptosis
  • Aquatic Organisms / chemistry
  • Cell Line, Tumor
  • Cell Survival
  • Humans
  • Male
  • Peptides / pharmacology
  • Peptides / therapeutic use
  • Prostatic Neoplasms* / drug therapy

Substances

  • Antineoplastic Agents
  • Peptides

Grants and funding

This research received no external funding.